TreeWAS – Variant ID: rs902774

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C61 Malignant neoplasm of prostate	0.979	0.021	0.000
C60-C63 Malignant neoplasms of male genital organs	0.446	0.554	0.000
C62 Malignant neoplasm of testis	0.332	0.668	0.000
C60 Malignant neoplasm of penis	0.326	0.674	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.320	0.680	0.000
C62.1 Descended testis	0.245	0.755	0.000
C62.9 Testis, unspecified	0.244	0.756	0.000
C60.9 Penis, unspecified	0.240	0.759	0.000
C62.0 Undescended testis	0.238	0.762	0.000
C60.8 Overlapping lesion of penis	0.234	0.766	0.000
C60.2 Body of penis	0.234	0.766	0.000
C60.1 Glans penis	0.234	0.766	0.000
C60.0 Prepuce	0.234	0.766	0.000
C63.9 Male genital organ, unspecified	0.229	0.771	0.000
C63.8 Overlapping lesion of male genital organs	0.229	0.771	0.000
C63.7 Other specified male genital organs	0.229	0.771	0.000
C63.2 Scrotum	0.229	0.771	0.000
C63.1 Spermatic cord	0.229	0.771	0.000
C63.0 Epididymis	0.229	0.771	0.000
T39.1 4-Aminophenol derivatives	0.000	0.968	0.032
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.022	0.978	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.981	0.019
T39.0 Salicylates	0.000	0.983	0.017
O32.1 Maternal care for breech presentation	0.015	0.985	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.985	0.015
T39.4 Antirheumatics, not elsewhere classified	0.000	0.986	0.014
T39.2 Pyrazolone derivatives	0.000	0.986	0.014
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.987	0.013
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.013	0.987	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.987	0.012
Z99.1 Dependence on respirator	0.012	0.988	0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.012	0.988	0.000
O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium	0.012	0.988	0.000
R32 Unspecified urinary incontinence	0.012	0.988	0.000
J92.9 Pleural plaque without asbestos	0.010	0.990	0.000
O15 Eclampsia	0.009	0.991	0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.009	0.991	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.991	0.009
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.009	0.991	0.000
O16 Unspecified maternal hypertension	0.009	0.991	0.000
O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium	0.009	0.991	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.008	0.992	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.008	0.992	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.008	0.992	0.000
O32.0 Maternal care for unstable lie	0.008	0.992	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.008	0.992	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.007	0.993	0.000
N13 Obstructive and reflux uropathy	0.007	0.993	0.000
O14.9 Preeclampsia, unspecified	0.007	0.993	0.000
O15.9 Eclampsia, unspecified as to time period	0.007	0.993	0.000
O15.2 Eclampsia in the puerperium	0.007	0.993	0.000
O15.1 Eclampsia in labour	0.007	0.993	0.000
O15.0 Eclampsia in pregnancy	0.007	0.993	0.000
O14.0 Moderate preeclampsia	0.007	0.993	0.000
O14.2 HELLP syndrome	0.007	0.993	0.000
K70.3 Alcoholic cirrhosis of liver	0.007	0.993	0.000
O12.2 Gestational oedema with proteinuria	0.006	0.994	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.006	0.994	0.000
G96.0 Cerebrospinal fluid leak	0.006	0.994	0.000
K70.1 Alcoholic hepatitis	0.006	0.994	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.000	0.994	0.006
N13.6 Pyonephrosis	0.006	0.994	0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.006	0.994	0.000
O12.0 Gestational oedema	0.006	0.994	0.000
O32.6 Maternal care for compound presentation	0.006	0.994	0.000
O14.1 Severe preeclampsia	0.005	0.995	0.000
O12.1 Gestational proteinuria	0.005	0.995	0.000
K70 Alcoholic liver disease	0.005	0.995	0.000
O32.2 Maternal care for transverse and oblique lie	0.005	0.995	0.000
O32.4 Maternal care for high head at term	0.005	0.995	0.000
O32.3 Maternal care for face, brow and chin presentation	0.005	0.995	0.000
O32.9 Maternal care for malpresentation of foetus, unspecified	0.005	0.995	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.005	0.995	0.000
N13.8 Other obstructive and reflux uropathy	0.005	0.995	0.000
K70.4 Alcoholic hepatic failure	0.005	0.995	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.005	0.995	0.000
G96 Other disorders of central nervous system	0.004	0.995	0.000
N13.4 Hydroureter	0.004	0.996	0.000
M25.57 Pain in joint (Ankle and foot)	0.000	0.996	0.004
Z85.4 Personal history of malignant neoplasm of genital organs	0.004	0.996	0.000
O32.8 Maternal care for other malpresentation of foetus	0.004	0.996	0.000
K70.0 Alcoholic fatty liver	0.004	0.996	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.004	0.996	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.004	0.996	0.000
J92 Pleural plaque	0.004	0.996	0.000
G96.9 Disorder of central nervous system, unspecified	0.003	0.996	0.000
G96.8 Other specified disorders of central nervous system	0.003	0.996	0.000
H54.4 Blindness, one eye	0.003	0.997	0.000
R61 Hyperhidrosis	0.000	0.997	0.003
D16.3 Short bones of lower limb	0.003	0.997	0.000
M25.55 Pain in joint (Pelvic region and thigh)	0.000	0.997	0.003
M22.4 Chondromalacia patellae	0.003	0.997	0.000
M22.2 Patellofemoral disorders	0.003	0.997	0.000
R61.1 Generalised hyperhidrosis	0.000	0.997	0.002
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
F17.2 Dependence syndrome	0.003	0.997	0.000
M25.5 Pain in joint	0.000	0.997	0.003
D21.2 Connective and other soft tissue of lower limb, including hip	0.003	0.997	0.000
M22 Disorders of patella	0.003	0.997	0.000
M25.58 Pain in joint (Other)	0.000	0.997	0.002
G24.9 Dystonia, unspecified	0.000	0.997	0.002
K70.9 Alcoholic liver disease, unspecified	0.002	0.997	0.000
M22.0 Recurrent dislocation of patella	0.002	0.998	0.000
N10 Acute tubulo-interstitial nephritis	0.002	0.998	0.000
M25.54 Pain in joint (Hand)	0.000	0.998	0.002
G06.1 Intraspinal abscess and granuloma	0.002	0.998	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.002	0.998	0.000
M24.23 Disorder of ligament (Forearm)	0.002	0.998	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.000	0.998	0.002
Y42.5 Other oestrogens and progestogens	0.002	0.998	0.000
J94.8 Other specified pleural conditions	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
R61.0 Localised hyperhidrosis	0.000	0.998	0.002
J94 Other pleural conditions	0.002	0.998	0.000
M25.50 Pain in joint (Multiple sites)	0.000	0.998	0.002
N10-N16 Renal tubulo-interstitial diseases	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
N13.3 Other and unspecified hydronephrosis	0.002	0.998	0.000
L29.0 Pruritus ani	0.000	0.998	0.002
M22.9 Disorder of patella, unspecified	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
G06 Intracranial and intraspinal abscess and granuloma	0.002	0.998	0.000
S32.50 Fracture of pubis (closed)	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
J94.9 Pleural condition, unspecified	0.002	0.998	0.000
J94.2 Haemothorax	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
M25.59 Pain in joint (Site unspecified)	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.002	0.998	0.000
J94.1 Fibrothorax	0.002	0.998	0.000
M22.1 Recurrent subluxation of patella	0.002	0.998	0.000
M22.3 Other derangements of patella	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
N48.0 Leukoplakia of penis	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
M25.52 Pain in joint (Upper arm)	0.000	0.998	0.002
M22.8 Other disorders of patella	0.002	0.998	0.000
T78.3 Angioneurotic oedema	0.000	0.998	0.002
G06.0 Intracranial abscess and granuloma	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
G00-G09 Inflammatory diseases of the central nervous system	0.002	0.998	0.000
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
J94.0 Chylous effusion	0.002	0.998	0.000
M79.67 Pain in limb (Ankle and foot)	0.000	0.998	0.002
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.002	0.998	0.000
C77.1 Intrathoracic lymph nodes	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
G04 Encephalitis, myelitis and encephalomyelitis	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
J80 Adult respiratory distress syndrome	0.002	0.998	0.000
H54 Blindness and low vision	0.002	0.998	0.000
H54.7 Unspecified visual loss	0.002	0.998	0.000
N48.1 Balanoposthitis	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
C77.2 Intra-abdominal lymph nodes	0.002	0.998	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
L29.2 Pruritus vulvae	0.000	0.998	0.002
R49.0 Dysphonia	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
M22.10 Recurrent subluxation of patella, unspecified knee	0.002	0.998	0.000
N15 Other renal tubulo-interstitial diseases	0.002	0.998	0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
G06.2 Extradural and subdural abscess, unspecified	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
L29.8 Other pruritus	0.000	0.998	0.002
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.002	0.998	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.998	0.002
K76.6 Portal hypertension	0.002	0.998	0.000
G03 Meningitis due to other and unspecified causes	0.002	0.998	0.000
L29 Pruritus	0.000	0.998	0.002
J90-J94 Other diseases of pleura	0.002	0.998	0.000
T18.1 Foreign body in oesophagus	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
Z92.8 Personal history of other medical treatment	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T78 Adverse effects, not elsewhere classified	0.000	0.998	0.002
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.001
T36.8 Other systemic antibiotics	0.000	0.998	0.001
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.001
T36.6 Rifamycins	0.000	0.998	0.001
T36.5 Aminoglycosides	0.000	0.998	0.001
T36.4 Tetracyclines	0.000	0.998	0.001
T36.3 Macrolides	0.000	0.998	0.001
T36.2 Chloramphenicol group	0.000	0.998	0.001
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.001
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.002	0.998	0.000
N11 Chronic tubulo-interstitial nephritis	0.002	0.998	0.000
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.998	0.002
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.001	0.998	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.001	0.998	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.001	0.998	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.001	0.998	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.001	0.998	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.001	0.998	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
Y95 Nosocomial condition	0.002	0.998	0.000
J38.2 Nodules of vocal cords	0.002	0.998	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.002	0.998	0.000
M46.46 Discitis, unspecified (Lumbar region)	0.002	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.001	0.998	0.000
G04.1 Tropical spastic paraplegia	0.001	0.998	0.000
G04.0 Acute disseminated encephalitis	0.001	0.998	0.000
M25.51 Pain in joint (Shoulder region)	0.000	0.998	0.002
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.001	0.998	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.001	0.998	0.000
H54.3 Unqualified visual loss, both eyes	0.001	0.998	0.000
H54.2 Low vision, both eyes	0.001	0.998	0.000
J93.9 Pneumothorax, unspecified	0.002	0.998	0.000
H54.1 Blindness, one eye, low vision, other eye	0.001	0.998	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.001	0.998	0.000
N14.3 Nephropathy induced by heavy metals	0.001	0.998	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.001	0.998	0.000
N14.0 Analgesic nephropathy	0.001	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.001
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.001
T46.7 Peripheral vasodilators	0.000	0.998	0.001
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.001
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.001
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.001
G01 Meningitis in bacterial diseases classified elsewhere	0.001	0.998	0.000
H54.5 Low vision, one eye	0.001	0.998	0.000
N15.1 Renal and perinephric abscess	0.001	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
G00 Bacterial meningitis, not elsewhere classified	0.001	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
G03.9 Meningitis, unspecified	0.001	0.998	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.001	0.998	0.000
N15.0 Balkan nephropathy	0.001	0.998	0.000
O42.9 Premature rupture of membranes, unspecified	0.000	0.998	0.002
S32.5 Fracture of pubis	0.001	0.998	0.000
T63.4 Venom of other arthropods	0.000	0.998	0.002
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.998	0.001
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.998	0.002
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.001	0.998	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.001	0.998	0.000
L29.3 Anogenital pruritus, unspecified	0.000	0.998	0.001
L29.1 Pruritus scroti	0.000	0.998	0.001
N48.8 Other specified disorders of penis	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.001
D63.0 Anaemia in neoplastic disease	0.002	0.998	0.000
G03.8 Meningitis due to other specified causes	0.001	0.998	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.001	0.998	0.000
G03.1 Chronic meningitis	0.001	0.998	0.000
G03.0 Nonpyogenic meningitis	0.001	0.998	0.000
M24.2 Disorder of ligament	0.001	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.001
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.001	0.998	0.000
M46.4 Discitis, unspecified	0.001	0.998	0.000
N89.5 Stricture and atresia of vagina	0.001	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.001
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.001
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.001
T78.9 Adverse effect, unspecified	0.000	0.998	0.001
T78.8 Other adverse effects, not elsewhere classified	0.000	0.998	0.001
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.000	0.999	0.001
M75.2 Bicipital tendinitis	0.001	0.999	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.001	0.999	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.001	0.999	0.000
T36.0 Penicillins	0.000	0.999	0.001
Z74.2 Need for assistance at home and no other household member able to render care	0.001	0.999	0.000
N48 Other disorders of penis	0.001	0.999	0.000
M24.21 Disorder of ligament (Shoulder region)	0.001	0.999	0.000
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
G02.1 Meningitis in mycoses	0.001	0.999	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.001	0.999	0.000
D17 Benign lipomatous neoplasm	0.000	0.999	0.001
J93 Pneumothorax	0.001	0.999	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.001	0.999	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
E21.0 Primary hyperparathyroidism	0.000	0.999	0.001
M54.46 Lumbago with sciatica (Lumbar region)	0.001	0.999	0.000
C77.9 Lymph node, unspecified	0.001	0.999	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.001	0.999	0.000
N11.1 Chronic obstructive pyelonephritis	0.001	0.999	0.000
N48.3 Priapism	0.001	0.999	0.000
H54.0 Blindness, both eyes	0.001	0.999	0.000
N48.9 Disorder of penis, unspecified	0.001	0.999	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.999	0.001
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.001	0.999	0.000
J92.0 Pleural plaque with presence of asbestos	0.001	0.999	0.000
S27.1 Traumatic haemothorax	0.000	0.999	0.001
T43.6 Psychostimulants with abuse potential	0.000	0.999	0.001
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.999	0.001
Y91.9 Alcohol involvement, not otherwise specified	0.001	0.999	0.000
S32.51 Fracture of pubis (open)	0.001	0.999	0.000
C45.9 Mesothelioma, unspecified	0.000	0.999	0.001
G00.8 Other bacterial meningitis	0.001	0.999	0.000
G00.3 Staphylococcal meningitis	0.001	0.999	0.000
G00.2 Streptococcal meningitis	0.001	0.999	0.000
G00.0 Haemophilus meningitis	0.001	0.999	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.001	0.999	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.999	0.001
Y42.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
Y42.4 Oral contraceptives	0.001	0.999	0.000
Y42.2 Antithyroid drugs	0.001	0.999	0.000
Y42.1 Thyroid hormones and substitutes	0.001	0.999	0.000
G00.1 Pneumococcal meningitis	0.001	0.999	0.000
L20.9 Atopic dermatitis, unspecified	0.000	0.999	0.001
Z88.1 Personal history of allergy to other antibiotic agents	0.001	0.999	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.001	0.999	0.000
Z99.4 Dependence on artificial heart	0.001	0.999	0.000
Z99.0 Dependence on aspirator	0.001	0.999	0.000
J91 Pleural effusion in conditions classified elsewhere	0.001	0.999	0.000
M46 Other inflammatory spondylopathies	0.001	0.999	0.000
M24.29 Disorder of ligament (Site unspecified)	0.001	0.999	0.000
M24.28 Disorder of ligament (Other)	0.001	0.999	0.000
M24.25 Disorder of ligament (Pelvic region and thigh)	0.001	0.999	0.000
M24.22 Disorder of ligament (Upper arm)	0.001	0.999	0.000
M24.20 Disorder of ligament (Multiple sites)	0.001	0.999	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.001	0.999	0.000
N87.0 Mild cervical dysplasia	0.001	0.999	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.001	0.999	0.000
M24.24 Disorder of ligament (Hand)	0.001	0.999	0.000
M46.49 Discitis, unspecified (Site unspecified)	0.001	0.999	0.000
M46.48 Discitis, unspecified (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M46.47 Discitis, unspecified (Lumbosacral region)	0.001	0.999	0.000
M46.45 Discitis, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M46.44 Discitis, unspecified (Thoracic region)	0.001	0.999	0.000
M46.43 Discitis, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M46.42 Discitis, unspecified (Cervical region)	0.001	0.999	0.000
M46.41 Discitis, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
M46.40 Discitis, unspecified (Multiple sites in spine)	0.001	0.999	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.001	0.999	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.001	0.999	0.000
N48.5 Ulcer of penis	0.001	0.999	0.000
N87.1 Moderate cervical dysplasia	0.001	0.999	0.000
R94.5 Abnormal results of liver function studies	0.000	0.999	0.001
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.999	0.001
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.000	0.999	0.001
E10.1 With ketoacidosis	0.001	0.999	0.000
G24.5 Blepharospasm	0.000	0.999	0.001
N87.9 Dysplasia of cervix uteri, unspecified	0.001	0.999	0.000
M19.99 Arthrosis, unspecified (Site unspecified)	0.001	0.999	0.000
F31.9 Bipolar affective disorder, unspecified	0.000	0.999	0.001
M46.0 Spinal enthesopathy	0.001	0.999	0.000
M25.53 Pain in joint (Forearm)	0.000	0.999	0.001
C91.1 Chronic lymphocytic leukaemia	0.000	0.999	0.001
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.999	0.001
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.999	0.001
T42.3 Barbiturates	0.000	0.999	0.001
T42.2 Succinimides and oxazolidinediones	0.000	0.999	0.001
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.999	0.001
G24 Dystonia	0.000	0.999	0.001
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.000	0.999	0.001
C45.0 Mesothelioma of pleura	0.000	0.999	0.001
J38.4 Oedema of larynx	0.001	0.999	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.001	0.999	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.001	0.999	0.000
M46.06 Spinal enthesopathy (Lumbar region)	0.001	0.999	0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.000	0.999	0.001
G00.9 Bacterial meningitis, unspecified	0.001	0.999	0.000
M46.8 Other specified inflammatory spondylopathies	0.001	0.999	0.000
M46.5 Other infective spondylopathies	0.001	0.999	0.000
M46.3 Infection of intervertebral disk (pyogenic)	0.001	0.999	0.000
M46.2 Osteomyelitis of vertebra	0.001	0.999	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.001	0.999	0.000
N48.2 Other inflammatory disorders of penis	0.001	0.999	0.000
F80.1 Expressive language disorder	0.000	0.999	0.001
J38.1 Polyp of vocal cord and larynx	0.001	0.999	0.000
T42.0 Hydantoin derivatives	0.000	0.999	0.001
T75.4 Effects of electric current	0.000	0.999	0.001
T88.7 Unspecified adverse effect of drug or medicament	0.000	0.999	0.001
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.999	0.001
N87 Dysplasia of cervix uteri	0.001	0.999	0.000
T68 Hypothermia	0.000	0.999	0.001
M13.96 Arthritis, unspecified (Lower leg)	0.001	0.999	0.000
M46.1 Sacro-iliitis, not elsewhere classified	0.001	0.999	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.999	0.001
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.001	0.999	0.000
M46.09 Spinal enthesopathy (Site unspecified)	0.001	0.999	0.000
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M46.07 Spinal enthesopathy (Lumbosacral region)	0.001	0.999	0.000
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.001	0.999	0.000
M46.04 Spinal enthesopathy (Thoracic region)	0.001	0.999	0.000
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.001	0.999	0.000
M46.02 Spinal enthesopathy (Cervical region)	0.001	0.999	0.000
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.001	0.999	0.000
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.001	0.999	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.999	0.001
J93.0 Spontaneous tension pneumothorax	0.001	0.999	0.000
D16 Benign neoplasm of bone and articular cartilage	0.001	0.999	0.000
Y91 Evidence of alcohol involvement determined by level of intoxication	0.001	0.999	0.000
M24.26 Disorder of ligament (Lower leg)	0.001	0.999	0.000
M79.69 Pain in limb (Site unspecified)	0.000	0.999	0.001
G24.4 Idiopathic orofacial dystonia	0.000	0.999	0.001
G24.2 Idiopathic nonfamilial dystonia	0.000	0.999	0.001
G24.1 Idiopathic familial dystonia	0.000	0.999	0.001
G24.0 Drug-induced dystonia	0.000	0.999	0.001
G99.2 Myelopathy in diseases classified elsewhere	0.001	0.999	0.000
N48.4 Impotence of organic origin	0.001	0.999	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
Z29.0 Isolation	0.000	0.999	0.001
M21.06 Valgus deformity, not elsewhere classified (Lower leg)	0.000	0.999	0.001
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.001	0.999	0.000
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M46.27 Osteomyelitis of vertebra (Lumbosacral region)	0.001	0.999	0.000
M46.26 Osteomyelitis of vertebra (Lumbar region)	0.001	0.999	0.000
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations